- -

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial

Show full item record

Rossetti, P.; Ampudia Blasco, FJ.; Laguna Sanz, AJ.; Revert Tomás, A.; Vehí Casellas, J.; Ascaso, JF.; Bondía Company, J. (2012). Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial. Diabetes Technology & Therapeutics. 14(11):1043-1052. doi:10.1089/dia.2012.0145

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/31150

Files in this item

Item Metadata

Title: Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial
Author:
UPV Unit: Universitat Politècnica de València. Departamento de Ingeniería de Sistemas y Automática - Departament d'Enginyeria de Sistemes i Automàtica
Universitat Politècnica de València. Instituto Universitario de Automática e Informática Industrial - Institut Universitari d'Automàtica i Informàtica Industrial
Issued date:
Abstract:
[EN] Objective: Prandial insulin dosing is an empirical practice associated frequently with poor reproducibility in postprandial glucose response. Based on continuous glucose monitoring (CGM), a method for prandial insulin ...[+]
Copyrigths: Reserva de todos los derechos
Source:
Diabetes Technology & Therapeutics. (issn: 1520-9156 ) (eissn: 1557-8593 )
DOI: 10.1089/dia.2012.0145
Publisher:
Mary Ann Liebert
Publisher version: http://dx.doi.org/10.1089/dia.2012.0145
Project ID: info:eu-repo/grantAgreement/EC/FP7/252085
Description: This is a copy of an article published in the Diabetes Technology and Therapeutics © 2012 [copyright Mary Ann Liebert, Inc.]; Diabetes Technology and Therapeutics is available online at: http://online.liebertpub.com.
Thanks:
We are grateful to Mrs. Sara Correa, Fundacion INCLIVA-Hospital Clinico Universitario de Valencia, and Mrs. Geles Viguer, Hospital Clinico Universitario de Valencia, for their invaluable help in conducting the study. We ...[+]
Type: Artículo

This item appears in the following Collection(s)

Show full item record